This frame evaluates whether an individual, company, or system is building durable leverage — or operating inside a dependency where rules, economics, or access can be changed unilaterally.

Most people focus on upside first.

They optimize growth, reach, distribution, or efficiency without examining who controls the interface, the rules, or the constraints underneath that upside.

Dependency often looks attractive early because it accelerates results. The cost only becomes visible when conditions change.

The clearest transaction I have led where this frame determined the outcome was the controlling stake acquisition of Long Beach Outpatient Surgery.

The GI physicians who owned the center had built something real — a functioning outpatient surgery facility with clean financials, a loyal surgical team, and years of operating history. But they were operating inside a dependency they could not see clearly from the inside. As a small, independent center, they had no negotiating power with insurance providers or Medicare. They were accepting reimbursement rates that a better-positioned facility would never accept. The same procedures, performed at the same quality level, were being paid at small-center rates because the center lacked the institutional affiliation required to negotiate otherwise.

The dependency was structural, not operational. The center ran well. The physicians were skilled. The problem was that the rules of their reimbursement relationship could be set unilaterally by payers — and the center had no leverage to change them.

The acquisition converted that dependency into leverage. Affiliating with Surgical Care Affiliates — a platform that was later acquired by UnitedHealth Group's Optum for $2.3 billion — gave the center access to negotiated rate structures it could never have achieved independently. GI reimbursement rates increased 20% per case post-rebrand. Not because the procedures changed. Because the institutional relationship changed.

The multi-specialty expansion that followed — cardiovascular, orthopedic, peripheral vascular, spine — compounded the leverage. Each new specialty brought higher-margin procedures and a more diversified revenue base. The center that had been a rate-constrained single-specialty dependency became a structurally advantaged multi-specialty platform. The value tripled over eight years.

The lesson is not specific to healthcare. Every business that depends on an external party to set the terms of its most important relationships is operating inside a dependency. The question is always the same: who owns the downside if those terms change?

Leverage exists when outcomes improve disproportionately with scale, while downside remains bounded or optional.

Dependency exists when upside is shared but downside is asymmetric — especially when another party can alter terms, access, or visibility at will.

• Who controls the primary interface or distribution layer
• Whether terms can be changed unilaterally
• How difficult it is to exit without loss of identity or audience
• Whether success increases bargaining power or erodes it

• Short-term traffic or usage spikes
• Platform-provided incentives that are reversible
• Prestige or perceived association with powerful intermediaries
• Consensus narratives about "where the industry is going"

This frame applies whenever success depends on an external system, platform, intermediary, or gatekeeper — especially in periods of technological transition.

It is foundational in evaluating media, technology platforms, marketplaces, capital structures, and AI-mediated visibility.

This frame is less relevant when outcomes are fully controlled, incentives are symmetric, and exit costs are low.

In those cases, optimization and execution matter more than structural positioning.